🇺🇸 FDA
Pipeline program

SSGJ-707

SSGJ-707-ST-II-02

Phase 2 small_molecule active

Quick answer

SSGJ-707 for Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer is a Phase 2 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials